These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3933793)

  • 1. Comparative bone analysis via inflammation-mediated osteopenia (IMO) in the rat.
    Bauss F; Minne HW; Sterz H; Weng U; Wesch H; Ziegler R
    Calcif Tissue Int; 1985 Sep; 37(5):539-46. PubMed ID: 3933793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia.
    Hadjidakis D; Lempert UG; Minne HW; Ziegler R
    Horm Metab Res; 1993 Feb; 25(2):77-81. PubMed ID: 8458612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity.
    Offley SC; Guo TZ; Wei T; Clark JD; Vogel H; Lindsey DP; Jacobs CR; Yao W; Lane NE; Kingery WS
    J Bone Miner Res; 2005 Feb; 20(2):257-67. PubMed ID: 15647820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of inflammation-mediated osteopenia (IMO) on the structure of rabbit bone and skin collagen fibrils.
    Kounadi E; Fountos G; Tzaphlidou M
    Connect Tissue Res; 1998; 37(1-2):69-76. PubMed ID: 9643648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat.
    Müller K; Wiesenberg I; Jaeggi K; Green JR
    Arzneimittelforschung; 1998 Jan; 48(1):81-6. PubMed ID: 9522039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass.
    Minne HW; Pfeilschifter J; Scharla S; Mutschelknauss S; Schwarz A; Krempien B; Ziegler R
    Endocrinology; 1984 Jul; 115(1):50-4. PubMed ID: 6547388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endogenous and exogenous calcitonin on inflammation-mediated osteopenia in the rat.
    Wüster C; Ding G; Minne HW; Ziegler R
    Horm Res; 1992; 37(3):119-23. PubMed ID: 1478626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation.
    Smith BJ; Lerner MR; Bu SY; Lucas EA; Hanas JS; Lightfoot SA; Postier RG; Bronze MS; Brackett DJ
    Bone; 2006 Mar; 38(3):378-86. PubMed ID: 16256450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-mediated osteopenia (IMO): no change in bone resorption during its development.
    Lempert UG; Minne HW; Fleisch H; Mühlbauer RC; Scharla SH; Ziegler R
    Calcif Tissue Int; 1991 Apr; 48(4):291-2. PubMed ID: 2059882
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature Fisher 344 × Brown Norway male rats.
    Durbin SM; Jackson JR; Ryan MJ; Gigliotti JC; Alway SE; Tou JC
    Appl Physiol Nutr Metab; 2012 Dec; 37(6):1179-88. PubMed ID: 23050779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral content in the senescent rat femur: an assessment using single photon absorptiometry.
    Kiebzak GM; Smith R; Howe JC; Sacktor B
    J Bone Miner Res; 1988 Jun; 3(3):311-7. PubMed ID: 3213624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
    Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
    Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabecular bone microarchitecture is deteriorated in men with spinal cord injury.
    Modlesky CM; Majumdar S; Narasimhan A; Dudley GA
    J Bone Miner Res; 2004 Jan; 19(1):48-55. PubMed ID: 14753736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption.
    Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL
    Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin secretion in rats with inflammation mediated osteopenia.
    Lopez A; Gozariu L; Orbai P; Barabaş E; Vlăduţiu T
    Endocrinologie; 1986; 24(3):167-9. PubMed ID: 3775223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion in magnesium silicate-induced osteopenia in rats.
    Orbai P; Gozariu L; Saramet-Comşa T
    Endocrinologie; 1991; 29(1-2):43-6. PubMed ID: 1803490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.